Results

Total Results: 534 records

Showing results for "prescription".

461. Disposition of Comments for CER 161 Major Depressive Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder-disposition-160504.pdf
     December 08, 2015 - be representative of the MDD population as a whole, and may start off favorably disposed to a non-prescription … data, which limits the strength of evidence data rating to “low”, and we note the caveat of SJW prescription

462. Disposition of Comments Report for Evidence Report/Technology Assessment No. 214 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_disposition-comments.pdf
     February 25, 2014 - personal followup, quit guide, and NRT) while three did not (clinic reinforcement, peer support, and prescription

463. Ch 6-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
     October 30, 2012 - Are total costs of interest, or costs associated with specific resources (e.g., prescription drug costs

464. Disposition of Comments for Pressure Ulcer Treatment Strategies: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
     May 08, 2013 - Nutrition supplementation is a low-risk, non- prescription therapy for pressure ulcers.

465. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs Future Research Needs Paper Number 23 Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs Future Research Nee…

466. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - The manufacturer announced a Prescription Drug User Fee Act (PDUFA) goal date of September 26, 2014 … announced that FDA had received its NDA resubmission and set October 17, 2013, as the therapy’s new Prescription

467. Crosscutting-Horizon-Scan-High-Impact-1512 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - delivered to patients in one of three ways, depending on the pharmacy’s capabilities and the physician’s prescription

468. Kidney-Stone-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
     March 01, 2013 - Food and Drug Administration and available in the United States either by prescription or over the

469. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
     June 30, 2016 - MEDICATION ADHERENCE FOR CHRONIC CONDITIONS: 50 patients "There was a trend toward increased prescription

470. Crosscutting-Horizon-Scan-High-Impact-1506 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - delivered to patients in one of three ways, depending on the pharmacy’s capabilities and the physician’s prescription

471. Crosscutting-Horizon-Scan-High-Impact-1412 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - delivered to patients in one of three ways, depending on the pharmacy’s capabilities and the physician’s prescription

472. Whole-Body Vibration Therapy for Osteoporosis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
     January 01, 2020 - As part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Congress directed

473. Topic Brief: Interventions to Decrease Hospital Length of Stay (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-hospital-length-of-stay.pdf
     November 01, 2019 - Family or patient’s readiness to leave hospital • Prolonged wait time for procedures, test results, or prescriptions

474. Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
     October 01, 2016 - catalytic converters in motor vehicles, restrictions on pesticides, reduction of lethality or toxicity of prescriptions … Addressing Moderated Mediation Hypotheses: Theory, Methods, and Prescriptions.

475. Dental Care for People With Sickle Cell Disease: A Rapid Response Literature Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sickle-cell-dental-rapid-response.pdf
     July 01, 2024 - care to facilitate preventive measures such as oral hygiene instructions, diet control, and fluoride prescription

476. Disposition of comments for CER 169 Low Back Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
     February 29, 2016 - However, opiate abuse, fueled by prescription opiates for chronic pain - mainly low back pain, is … When one looks at everything we do in pain management from interventional procedures to the prescription

477. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
     January 01, 2021 - Control (n=20) TAU: pharmacological treatment under medical prescription A vs.

478. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
     January 01, 2021 - Control (n=20) TAU: pharmacological treatment under medical prescription A vs.

479. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-knee-update-disposition-archived.pdf
     May 04, 2017 - Treatment of Osteoarthritis of the Knee: An Update Review Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Treatment of Osteoarthritis of the Knee: An Update Review Draft review available for public comment from September 13, 2016 to October 11, 2016. Research Review Citati…

480. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-disposition.pdf
     May 04, 2017 - Treatment of Osteoarthritis of the Knee: An Update Review Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Treatment of Osteoarthritis of the Knee: An Update Review Draft review available for public comment from September 13, 2016 to October 11, 2016. Resear…